Praxisbezogene Empfehlungen zum Ambulanten Glukoseprofil

Zusammenfassung

Kontinuierliches Glukosemonitoring resultiert in großen Datenmengen, die mithilfe des Ambulanten Glukoseprofils (AGP) standardisiert zusammengefasst und grafisch dargestellt werden können. Das AGP ermöglicht die Auswertung der Glukosewerte hinsichtlich verschiedener Parameter wie Hypo- und Hyperglykämien, Zeit im Zielbereich (Time in Range – TIR), Glukosevariabilität, Glukosestabilität und Glucose Exposure. Des Weiteren ermöglicht es eine einfache und verständliche Interpretation des glykämischen Profils. Sich daraus ergebende Therapie- und Verhaltensanpassungen können die glykämische Kontrolle von Menschen mit Diabetes verbessern. Die vorliegenden praxisnahen Empfehlungen zur Auswertung des AGP stellen eine Expertenmeinung dar, die von praxisnahen Diabetologen erstellt wurde. Anhand von Beispielen und Empfehlungen wird das Vorgehen schrittweise erläutert und zusammengefasst.

Abstract

Continuous glucose monitoring results in high amounts of data that can be summarized and visualized in a standardized manner using the ambulatory glucose profile (AGP). AGP enables the analysis of hypo- and hyperglycemia, time in range (TIR), glucose variability, glucose stability and glucose exposure. It allows an easy and understandable interpretation of the glycemic profile. The resulting changes in treatment and behavior may improve the patients’ glycemic control. The present practical recommendations for the evaluation of the AGP represent an expert opinion provided by practical diabetologists. Using examples and recommendations, the procedure is explained step-by-step and summarised.

Schlüsselwörter

AGP - Expertenempfehlung - Ambulantes Glukoseprofil - Time in Range - Flash-Glukosemonitoring - kontinuierliches Glukosemonitoring

Key words

AGP - expert recommendation - ambulatory glucose profile - time in range - flash glucose monitoring - continuous glucose monitoring

• Literatur

• 1 Mazze RS, Lucido D, Langer O. et al. Ambulatory glucose profile: representation of verified self-monitored blood glucose data. Diabetes Care 1987; 10: 111-117
• 2 Mazze RS, Strock E, Wesley D. et al. Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. Diabetes Technology & Therapeutics 2008; 10: 149-159
• 3 Bergenstal RM, Ahmann AJ, Bailey T. et al. Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile. Journal of Diabetes Science and Technology 2013; 7: 562-578
• 4 Matthaei S. Assessing the value of the Ambulatory Glucose Profile in clinical practice. The British Journal of Diabetes and Vascular Disease 2014; 14: 148-152
• 5 Matthaei S, Dealaiz RA, Bosi E. et al. Consensus recommendations for the use of Ambulatory Glucose Profile in clinical practice. The British Journal of Diabetes and Vascular Disease 2014; 14: 153-157
• 6 Siegmund T, Matthaei S, Reuter M. et al. Ambulantes Glukoseprofil (AGP): Empfehlungen zum Einsatz in der klinischen Praxis. Diabetes Stoffwechsel und Herz 2015; 24: 115-120
• 7 Dunn TC, Crouther N. Assessment of the variance of the ambulatory glucose profile over 3 to 20 days of continuous glucose monitoring. Diabetologia 2010; 53: 421
• 8 Mazze RS, Strock ES, Bergenstal RM. et al. Characterization of Glucose Metabolism. In: Staged Diabetes Management. Wiley-Blackwell; 2011: 29-39
• 9 Evans M, Cranston I, Bailey CJ. Amulatory glucose profile (AGP): utility in UK clinical practice. The British Journal of Diabetes 2017; 17: 28-33
• 10 Danne T, Nimri R, Battelino T. et al. International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care 2017; 40: 1631-1640
• 11 Agiostratidou G, Anhalt H, Ball D. et al. Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange. Diabetes Care 2017; 40: 1622-1630
• 12 Gandhi GY, Kovalaske M, Kudva Y. et al. Efficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: a systematic review and meta-analysis of randomized trials. J Diabetes Sci Technol 2011; 5: 952-965
• 13 Sartore G, Chilelli NC, Burlina S. et al. The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM). Acta diabetologica 2012; 49 (Suppl. 01) S153-S160
• 14 Beck RW, Hirsch IB, Laffel L. et al. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009; 32: 1378-1383
• 15 O’Connell MA, Donath S, O’Neal DN. et al. Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial. Diabetologia 2009; 52: 1250-1257
• 16 Group TJDRFCGMS. Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes. New England Journal of Medicine 2008; 359: 1464-1476
• 17 Holman RR, Paul SK, Bethel MA. et al. 10-year follow-up of intensive glucose control in type 2 diabetes. The New England journal of medicine 2008; 359: 1577-1589
• 18 Shafiee G, Mohajeri-Tehrani M, Pajouhi M. et al. The importance of hypoglycemia in diabetic patients. Journal of diabetes and metabolic disorders 2012; 11: 1-7
• 19 International Hypoglycaemia Study Group. Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2017; 40: 155-157
• 20 Karter AJ, Ackerson LM, Darbinian JA. et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. The American journal of medicine 2001; 111: 1-9
• 21 Kilpatrick ES, Rigby AS, Atkin SL. Mean blood glucose compared with HbA1c in the prediction of cardiovascular disease in patients with type 1 diabetes. Diabetologia 2008; 51: 365-371
• 22 Lin CC, Li CI, Yang SY. et al. Variation of fasting plasma glucose: a predictor of mortality in patients with type 2 diabetes. The American journal of medicine 2012; 125: 416.e419-418
• 23 Hanefeld M, Fischer S, Julius U. et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 1996; 39: 1577-1583
• 24 Monnier L, Colette C. Glycemic variability: should we and can we prevent it?. Diabetes Care 2008; 31 (Suppl. 02) S150-S154
• 25 DeVries JH. Glucose Variability: Where It Is Important and How to Measure It. Diabetes 2013; 62: 1405-1408
• 26 Monnier L, Colette C, Wojtusciszyn A. et al. Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes. Diabetes Care 2017; 40: 832-838
• 27 Marks V. Glycaemic stability in healthy subjects: fluctuations in blood glucose concentration during the day. In: Andreani D, Marks V, Lefèbvre P. Hrsg Hypoglycemia. New York: Raven Press; 1987: 19-24
• 28 Thomas L. Labor und Diagnose. 8. Auflage.. Aufl: TH-Books Verlagsgesellschaft mbH; 2012
• 29 Distiller LA, Cranston I, Mazze R. First Clinical Experience with Retrospective Flash Glucose Monitoring (FGM) Analysis in South Africa: Characterizing Glycemic Control with Ambulatory Glucose Profile. Journal of Diabetes Science and Technology 2016; 10: 1294-1302
• 30 Matthews JN, Altman DG, Campbell MJ. et al. Analysis of serial measurements in medical research. BMJ (Clinical research ed) 1990; 300: 230-235
• 31 Omar AS, Salama A, Allam M. et al. Association of time in blood glucose range with outcomes following cardiac surgery. BMC Anesthesiology 2015; 15: 14
• 32 Rickels MR, Peleckis AJ, Markmann E. et al. Long-Term Improvement in Glucose Control and Counterregulation by Islet Transplantation for Type 1 Diabetes. The Journal of clinical endocrinology and metabolism 2016; 101: 4421-4430